Skip to main content

Advertisement

Table 1 Clinical Characteristics of the patient cohort

From: A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target

Characteristics MCC (N = 18) BCC (N = 3) SCC (N = 3)
Sex
 Female 7 2 2
 Male 4 1 1
mean (SD)[range] years
 Total 72.06 (12.24) [41–93] 79 (7.21) [73–87] 78.3 (4.04) [74–82]
 Female 71.77 (12.93) [41–93] 82 (7.07) [77–87] 80.5 (2.12) [79–82]
Localization
 Head and/or Neck 2/18 (11%) 2/3 (66.6%) 3/3 (100%)
 Trunk 1/18 (5.5%) 1/3 (33%)  
 Extremities 15/18 (83%)   
MCPyV expression
 Positive 17/18 (94.4%) 1/3 (trace level T-ag)  
 Negative 1/18 (5.5%) 2/3 (66.6%) 3/3 (100%)
Stage AJCC (2019)
 I 2/18 (11.1%) 3/3 (100%) 3/3 (100%)
 IIA 4/18 (22.2%)   
 IIB 1/18 (5.5%)   
 IIIB 1/18 (5.5%)   
 IV 10/18 (60%)   
Current Status
 Dead 9/11 (82%)   
 Alive 2/11 (18%) 3/3 (100%) 3/3 (100%)